Science Explorer Back to mapMap

Most cited papers from U-M Rogel Cancer Center

What are the most cited papers from U-M Rogel Cancer Center?

The most cited paper from U-M Rogel Cancer Center is "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1" (Daniel J. Klionsky et al., 2021), with 2,743 citations. Next come "Amplification of a gene encoding a p53-associated protein in human sarcomas" (1,969) and "Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer" (1,713).

Showing 50 of 60 papers. Every paper with more than 367 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors 2 Jan 2021 2,743
2 Amplification of a gene encoding a p53-associated protein in human sarcomas Jonathan D. Oliner, Kenneth W. Kinzler, Paul S. Meltzer et al. · Nature Jul 1992 1,969
3 Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer Marshall R. Posner et al. · New England Journal of Medicine Open access 24 Oct 2007 1,713
4 Mindfulness and Emotion Regulation: The Development and Initial Validation of the Cognitive and Affective Mindfulness Scale-Revised (CAMS-R) Greg C. Feldman, Adele M. Hayes, Sameet M. Kumar et al. · Journal of Psychopathology and Behavioral Assessment 6 Nov 2006 1,651
5 Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome Richard W. Tothill, Anna V. Tinker, Joshy George et al. · Clinical Cancer Research 12 Aug 2008 1,525
6 Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Heather Hampel, Wendy L. Frankel, Edward W. Martin et al. · New England Journal of Medicine Open access 4 May 2005 1,433
7 Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology Al B. Benson et al. · Journal of the National Comprehensive Cancer Network Open access Mar 2017 1,375
8 Germ-Line Mutations in Nonsyndromic Pheochromocytoma Hartmut P.H. Neumann et al. · New England Journal of Medicine Open access 9 May 2002 1,373
9 Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML Alexander E. Perl et al. · New England Journal of Medicine Open access 30 Oct 2019 1,285
10 All-trans-Retinoic Acid in Acute Promyelocytic Leukemia Martin S. Tallman, Janet W. Andersen, Charles Alan Schiffer et al. · New England Journal of Medicine 9 Oct 1997 1,099
11 Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) L. Austin Doyle, Douglas D. Ross · Oncogene 20 Oct 2003 1,050
12 Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology Al B. Benson et al. · Journal of the National Comprehensive Cancer Network Open access Jul 2018 1,001
13 Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain Lixin Sun, Ai-Min Hui, Qin Su et al. · Cancer Cell Open access Apr 2006 911
14 Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma Krystian Jażdżewski, Elizabeth L. Murray, Kaarle Franssila et al. · Proceedings of the National Academy of Sciences Open access 12 May 2008 865
15 Consensus guidelines for the detection of immunogenic cell death Oliver Kepp et al. · OncoImmunology Open access 2 Sep 2014 842
16 KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study Bijal Dinesh Shah et al. · The Lancet Open access 4 Jun 2021 815
17 Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Loretta J. Nastoupil et al. · Journal of Clinical Oncology Open access 13 May 2020 812
18 Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer Feng Jiang, Qi Qiu, Abha Khanna et al. · Molecular Cancer Research Open access 10 Mar 2009 800
19 The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) Ezra E.W. Cohen, R. Bryan Bell, Carlo Bruno Bifulco et al. · Journal for ImmunoTherapy of Cancer Open access 15 Jul 2019 756
20 Identification of Targetable FGFR Gene Fusions in Diverse Cancers Yi-Mi Wu et al. · Cancer Discovery Open access 4 Apr 2013 746
21 PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress Francisca Vázquez, Ji‐Hong Lim, Helen Chim et al. · Cancer Cell Open access 14 Feb 2013 724
22 A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers Ashton C. Berger et al. · Cancer Cell Open access773 authors Apr 2018 702
23 Germline Mutations in HOXB13 and Prostate-Cancer Risk Charles M. Ewing et al. · New England Journal of Medicine Open access 11 Jan 2012 678
24 The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast Melvin J. Silverstein, Michael D. Lagios, Susan G. Groshen et al. · New England Journal of Medicine Open access 13 May 1999 674
25 Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells Hsing-Chen Tsai et al. · Cancer Cell Open access Mar 2012 658
26 Genetic/Familial High-Risk Assessment: Breast and Ovarian Mary B. Daly et al. · Journal of the National Comprehensive Cancer Network Open access May 2010 650
27 NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018 Alexander Dimitrios Colevas et al. · Journal of the National Comprehensive Cancer Network Open access May 2018 642
28 Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study Udai Banerji, Carla M.L. van Herpen, Cristina Saura et al. · The Lancet Oncology Open access 27 Jun 2019 577
29 Detection of functional haematopoietic stem cell niche using real-time imaging Yucai Xie, Tong Yin, Winfried Wiegraebe et al. · Nature 3 Dec 2008 552
30 NCCN Guidelines Insights: Breast Cancer, Version 1.2017 William John Gradishar et al. · Journal of the National Comprehensive Cancer Network Open access Apr 2017 545
31 Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Meng Law, Robert J. Young, James S. Babb et al. · Radiology Open access 19 Mar 2008 536
32 NCCN Guidelines Insights: Prostate Cancer, Version 1.2021 Edward Matthew Schaeffer et al. · Journal of the National Comprehensive Cancer Network Open access Feb 2021 532
33 Acute graft-versus-host disease does not require alloantigen expression on host epithelium Takanori Teshima, Rainer Ordemann, Pavan R. Reddy et al. · Nature Medicine Jun 2002 522
34 Psychological, social, and behavioral issues for young adults with cancer Brad Zebrack · Cancer Open access 26 Apr 2011 516
35 Mutation of the PIK3CA oncogene in human cancers Bedri Karakas, Kurtis E. Bachman, B H Park · British Journal of Cancer Open access 31 Jan 2006 504
36 Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative Ellen Stelloo, Tjalling Bosse, Remi A. Nout et al. · Modern Pathology Open access 27 Feb 2015 500
37 Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study Alexander E. Perl et al. · The Lancet Oncology Open access 21 Jun 2017 498
38 Two Thousand Transhiatal Esophagectomies Mark B. Orringer, Becky Marshall, Andrew C. Chang et al. · Annals of Surgery Open access 20 Aug 2007 488
39 A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life Siri Beier Jensen et al. · Supportive Care in Cancer Review 16 Mar 2010 476
40 Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation Vincent T. Ho, Corey S. Cutler, Shelly Carter et al. · Transplantation and Cellular Therapy Open access 22 Jul 2005 460
41 Breast Cancer Robert W. Carlson et al. · Journal of the National Comprehensive Cancer Network Open access Feb 2009 452
42 Gene expression in papillary thyroid carcinoma reveals highly consistent profiles Ying Sheng Huang, Manju Lata Prasad, William J. Lemon et al. · Proceedings of the National Academy of Sciences Open access 18 Dec 2001 448
43 Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann et al. · Blood Jun 2001 446
44 Animal Models for Medical Countermeasures to Radiation Exposure Jacqueline P. Williams, Stephen L. Brown, George E. Georges et al. · Radiation Research Open access 24 Mar 2010 427
45 The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology Eugene J. Gardner, Vincent Kwok Lim Lam, Daniel Harris et al. · Genome Research Open access 30 Aug 2017 420
46 Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis☆, ☆☆ Shu Man Fu, Krishnan Ramanujam, April S. Y. Wong et al. · Gastroenterology Open access Jun 1999 409
47 Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance Karthika Natarajan, Yi Xie, Maria R. Baer et al. · Biochemical Pharmacology Open access 11 Jan 2012 408
48 Aromatase, aromatase inhibitors, and breast cancer Saranya Chumsri, Timothy R. Howes, Ting Bao et al. · The Journal of Steroid Biochemistry and Molecular Biology Open access 17 Feb 2011 402
49 Cancer incidence in Nigeria: A report from population-based cancer registries Elima Enaji Jedy-Agba, María Paula Curado, Olufemi John Ogunbiyi et al. · Cancer Epidemiology Open access 22 May 2012 401
50 A role for mitochondrial enzymes in inherited neoplasia and beyond Charis Eng, Maija H. Kiuru, Magali J. Fernandez et al. · Nature reviews. Cancer Review 28 Feb 2003 395

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.